932 related articles for article (PubMed ID: 32938767)
1. Covalent Modifications of the Bacteriophage Genome Confer a Degree of Resistance to Bacterial CRISPR Systems.
Liu Y; Dai L; Dong J; Chen C; Zhu J; Rao VB; Tao P
J Virol; 2020 Nov; 94(23):. PubMed ID: 32938767
[TBL] [Abstract][Full Text] [Related]
2. Bacteriophage T4 Escapes CRISPR Attack by Minihomology Recombination and Repair.
Wu X; Zhu J; Tao P; Rao VB
mBio; 2021 Jun; 12(3):e0136121. PubMed ID: 34154416
[TBL] [Abstract][Full Text] [Related]
3. Landscape of New Nuclease-Containing Antiphage Systems in Escherichia coli and the Counterdefense Roles of Bacteriophage T4 Genome Modifications.
Wang S; Sun E; Liu Y; Yin B; Zhang X; Li M; Huang Q; Tan C; Qian P; Rao VB; Tao P
J Virol; 2023 Jun; 97(6):e0059923. PubMed ID: 37306585
[TBL] [Abstract][Full Text] [Related]
4. CRISPR/Cas9-mediated phage resistance is not impeded by the DNA modifications of phage T4.
Yaung SJ; Esvelt KM; Church GM
PLoS One; 2014; 9(6):e98811. PubMed ID: 24886988
[TBL] [Abstract][Full Text] [Related]
5. Covalent Modification of Bacteriophage T4 DNA Inhibits CRISPR-Cas9.
Bryson AL; Hwang Y; Sherrill-Mix S; Wu GD; Lewis JD; Black L; Clark TA; Bushman FD
mBio; 2015 Jun; 6(3):e00648. PubMed ID: 26081634
[TBL] [Abstract][Full Text] [Related]
6. Bacteriophage DNA glucosylation impairs target DNA binding by type I and II but not by type V CRISPR-Cas effector complexes.
Vlot M; Houkes J; Lochs SJA; Swarts DC; Zheng P; Kunne T; Mohanraju P; Anders C; Jinek M; van der Oost J; Dickman MJ; Brouns SJJ
Nucleic Acids Res; 2018 Jan; 46(2):873-885. PubMed ID: 29253268
[TBL] [Abstract][Full Text] [Related]
7. Unexpected evolutionary benefit to phages imparted by bacterial CRISPR-Cas9.
Tao P; Wu X; Rao V
Sci Adv; 2018 Feb; 4(2):eaar4134. PubMed ID: 29457136
[TBL] [Abstract][Full Text] [Related]
8. Engineering T4 Bacteriophage for
Dong J; Chen C; Liu Y; Zhu J; Li M; Rao VB; Tao P
ACS Synth Biol; 2021 Oct; 10(10):2639-2648. PubMed ID: 34546037
[TBL] [Abstract][Full Text] [Related]
9. Anti-CRISPR proteins: Counterattack of phages on bacterial defense (CRISPR/Cas) system.
Chaudhary K; Chattopadhyay A; Pratap D
J Cell Physiol; 2018 Jan; 233(1):57-59. PubMed ID: 28247934
[TBL] [Abstract][Full Text] [Related]
10. CRISPR-Cas and restriction-modification systems are compatible and increase phage resistance.
Dupuis MÈ; Villion M; Magadán AH; Moineau S
Nat Commun; 2013; 4():2087. PubMed ID: 23820428
[TBL] [Abstract][Full Text] [Related]
11. A jumbo phage that forms a nucleus-like structure evades CRISPR-Cas DNA targeting but is vulnerable to type III RNA-based immunity.
Malone LM; Warring SL; Jackson SA; Warnecke C; Gardner PP; Gumy LF; Fineran PC
Nat Microbiol; 2020 Jan; 5(1):48-55. PubMed ID: 31819217
[TBL] [Abstract][Full Text] [Related]
12. Conquering CRISPR: how phages overcome bacterial adaptive immunity.
Malone LM; Birkholz N; Fineran PC
Curr Opin Biotechnol; 2021 Apr; 68():30-36. PubMed ID: 33113496
[TBL] [Abstract][Full Text] [Related]
13. Engineering of Bacteriophage T4 Genome Using CRISPR-Cas9.
Tao P; Wu X; Tang WC; Zhu J; Rao V
ACS Synth Biol; 2017 Oct; 6(10):1952-1961. PubMed ID: 28657724
[TBL] [Abstract][Full Text] [Related]
14. Function and regulation of clustered regularly interspaced short palindromic repeats (CRISPR) / CRISPR associated (Cas) systems.
Richter C; Chang JT; Fineran PC
Viruses; 2012 Oct; 4(10):2291-311. PubMed ID: 23202464
[TBL] [Abstract][Full Text] [Related]
15. Resistance is not futile: bacterial 'innate' and CRISPR-Cas 'adaptive' immune systems.
Fineran PC
Microbiology (Reading); 2019 Aug; 165(8):834-841. PubMed ID: 30958259
[TBL] [Abstract][Full Text] [Related]
16. Molecular mechanisms of CRISPR-mediated microbial immunity.
Gasiunas G; Sinkunas T; Siksnys V
Cell Mol Life Sci; 2014 Feb; 71(3):449-65. PubMed ID: 23959171
[TBL] [Abstract][Full Text] [Related]
17. CRISPR-Cas9 Based Bacteriophage Genome Editing.
Zhang X; Zhang C; Liang C; Li B; Meng F; Ai Y
Microbiol Spectr; 2022 Aug; 10(4):e0082022. PubMed ID: 35880867
[TBL] [Abstract][Full Text] [Related]
18. Cas13-induced cellular dormancy prevents the rise of CRISPR-resistant bacteriophage.
Meeske AJ; Nakandakari-Higa S; Marraffini LA
Nature; 2019 Jun; 570(7760):241-245. PubMed ID: 31142834
[TBL] [Abstract][Full Text] [Related]
19. Impact of Different Target Sequences on Type III CRISPR-Cas Immunity.
Maniv I; Jiang W; Bikard D; Marraffini LA
J Bacteriol; 2016 Jan; 198(6):941-50. PubMed ID: 26755632
[TBL] [Abstract][Full Text] [Related]
20. Parasite Exposure Drives Selective Evolution of Constitutive versus Inducible Defense.
Westra ER; van Houte S; Oyesiku-Blakemore S; Makin B; Broniewski JM; Best A; Bondy-Denomy J; Davidson A; Boots M; Buckling A
Curr Biol; 2015 Apr; 25(8):1043-9. PubMed ID: 25772450
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
